Variation in the plasma membrane monoamine transporter (PMAT) (encoded by SLC29A4) and organic cation transporter 1 (OCT1) (encoded by SLC22A1) and gastrointestinal intolerance to metformin in type 2 diabetes: an IMI DIRECT study
However, tirzepatide (Mounjaro), Wegovy (semaglutide), and liraglutide (Nevolat) have all been shown to effectively support weight loss
It is not suitable for use during pregnancy, breastfeeding, or in people under 18 years of age
These two peptides have shown potential for complementary interaction because they target different biological mechanisms
This level of verification might seem excessive for a routine injection
Most digestive symptoms are dose-dependent, occurring during treatment initiation or dose escalation, and typically improve over time